Where is Lupin Pharma located?
Lupin Pharmaceuticals, Inc., the primary United States subsidiary and regional operational arm of the multinational pharmaceutical enterprise Lupin Limited, has its corporate headquarters located in Baltimore, Maryland, United States. The principal executive offices are situated within the Harborplace Tower along South Calvert Street in downtown Baltimore. From this Mid-Atlantic base, the subsidiary coordinates clinical research programs, regulatory affairs, product marketing, and pharmaceutical distribution networks supporting healthcare providers and patients across North America.
Related FAQs
Lupin Limited targets sustained financial and operational recovery through enhanced execution in its core North American generic portfolio, complex injectables, and domestic branded formulation markets.
Lupin is not a domestic United States enterprise, functioning instead as an Indian multinational pharmaceutical corporation with its corporate headquarters and primary executive governance located in Mumbai, India.
Lupin Limited is the official full corporate name of the prominent multinational pharmaceutical enterprise headquartered in Mumbai, India.
Lupin Limited continually expands its global pharmaceutical portfolio by launching complex generics, biosimilars, and specialty therapeutic medications targeting respiratory conditions, cardiovascular diseases, diabetes, and anti-infective treatments...
Lupin Pharmaceuticals is particularly famous for its pioneering development and large-scale manufacturing of anti-tuberculosis (TB) drugs, which at one point solidified its status as the world’s leading producer in that category.
Lupin Limited is the actual and official corporate name of the prominent multinational pharmaceutical company founded in India, rather than being derived from a fictional literary character or a code name. Established by Dr.
Lupin Limited, one of India's most prominent multinational pharmaceutical and biotechnology enterprises, traces its early corporate origins back to its establishment by founder Desh Bandhu Gupta under a modest proprietary setup that later incorporate...
Lupin Limited is a major Indian multinational pharmaceutical enterprise that specializes in developing, manufacturing, and globally distributing a wide portfolio of branded and generic formulations, biotechnology products, and active pharmaceutical i...
Lupin Limited operates as an extensive multinational pharmaceutical enterprise with a robust commercial presence spanning over 100 countries across the globe.
Lupin Limited is a leading Indian multinational pharmaceutical corporation headquartered in Mumbai.
Lupin Limited ranks securely among the top-tier pharmaceutical companies in India, holding a prominent leadership position in domestic prescription sales and global generic drug development.
Lupin Limited, a major multinational pharmaceutical enterprise specializing in pediatric, cardiovascular, anti-infective, diabetology, asthma, and gastrointestinal medications, has its primary global corporate headquarters located in Mumbai, Maharash...
Lupin originates from neither Japan nor France, establishing its roots entirely as an Indian pharmaceutical powerhouse founded in Mumbai by Dr. Desh Bandhu Gupta.
The proper name Lupin has botanical and literary roots, deriving from the Latin lupus, meaning wolf, because ancient naturalists mistakenly believed the flowering plant exhausted the soil like a wolf preys on herds.
Lupin Limited is an Indian multinational pharmaceutical giant famous for its massive global scale and its historic role as one of the world's leading manufacturers of anti-tuberculosis (TB) medications.
Lupin Limited was officially founded in Mumbai, India, in 1968 by visionary entrepreneur and philanthropist Dr. Desh Bandhu Gupta.
Mainfreight operates an extensive global supply chain and logistics network spanning 27 different countries worldwide.
Lupin Limited is a major global pharmaceutical corporation manufacturing a comprehensive portfolio of branded and generic formulations, active pharmaceutical ingredients, and biotechnology products.
Equity research analysts covering Lupin Limited generally issue favorable consensus ratings, highlighting its strong market leadership in complex generics, robust branded formulation portfolios in India, and steady operational turnaround momentum.
Lupin Limited is widely recognized as a major, highly reputable multinational pharmaceutical enterprise holding a strong market footprint in both generic and branded formulations globally.